Liver Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. May 15, 2003; 9(5): 941-945
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.941
Table 1 The ratios of cell proliferation of HCC in different diameter and benign hyperplastic nodules (%, -x±s)
Characteristics of fociNumber of casesDNA analysis of each period
G1 periodS periodG2/Mperiod
The group with HCC > 3 cm (A)2040.3 ± 6.843.5 ± 7.416.2 ± 1.7
The group with HCC ≤ 3 cm(B)2657.7 ± 5.830.4 ± 5.211.9 ± 1.1
The group with IBHN (C)1294.8 ± 0.72.6 ± 0.52.6 ± 0.4
Table 2 Cell proliferative ratios of 22 cases with HCC before and after ultrasound-guided interventional therapy (%, -x± s)
Time of detectEach period of cell proliferation (%)
G1 periodS periodG2/Mperiod
Before therapy(a)52.6 ± 7.237.5 ± 8.19.9 ± 1.9
After therapy(b)94.7 ± 4.13.7 ± 2.51.6 ± 0.5